Bi-Weekly Administration of Docetaxel for Older Men With Hormone Refractory Prostate Cancer
Status:
Completed
Trial end date:
2007-07-01
Target enrollment:
Participant gender:
Summary
This pilot study is designed to determine the feasibility and safety of administering
docetaxel at various dosing levels on a bi-weekly schedule in older men with hormone
refractory prostate cancer.